Cargando…
Glucose-Lowering Medication Use in CKD: Analysis of US Medicare Beneficiaries Between 2007 and 2016
BACKGROUND: Information regarding the use of glucose-lowering medications in patients with chronic kidney disease (CKD) is limited. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: Medicare 5% random sample of patients with CKD with type 2 diabetes, 2007 to 2016. PREDICTORS: Stu...
Autores principales: | Zhao, Julie Z., Weinhandl, Eric D., Carlson, Angeline M., St. Peter, Wendy L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039422/ https://www.ncbi.nlm.nih.gov/pubmed/33851113 http://dx.doi.org/10.1016/j.xkme.2020.09.016 |
Ejemplares similares
-
Disparities in SGLT2 Inhibitor or Glucagon-Like Peptide 1 Receptor Agonist Initiation Among Medicare-Insured Adults With CKD in the United States
por: Zhao, Julie Z., et al.
Publicado: (2022) -
Hypoglycemia Risk With SGLT2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists Versus Sulfonylureas Among Medicare Insured Adults With CKD in the United States
por: Zhao, Julie Z., et al.
Publicado: (2022) -
Medicare Part D: Selected Issues for Pharmacists and Beneficiaries in 2007
por: Kilian, Janet, et al.
Publicado: (2007) -
Beneficiary Switching Between Traditional Medicare and Medicare Advantage Between 2016 and 2020
por: Unuigbe, Aig, et al.
Publicado: (2022) -
Antihypertensive Medication Classes Used among Medicare Beneficiaries Initiating Treatment in 2007–2010
por: Kent, Shia T., et al.
Publicado: (2014)